Janet Woodcock MD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Richard Platt MD, MSc; Department of Population Medicine, Harvard Pilgrim Healthcare and Harvard Medical School, Boston, MA
Marsha Reichman PhD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Karen Midthun MD; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD
Michael Nguyen MD; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD
Darren Toh ScD; Department of Population Medicine, Harvard Pilgrim Healthcare Institute and Harvard Medical School, Boston, MA
Melissa Butler PharmD, PhD, MPH, BCPS; Kaiser Permanente Southeast, Atlanta, GA;
Katherine Yih PhD, MPH; Department of Population Medicine, Harvard Pilgrim Healthcare Institute and Harvard Medical School, Boston, MA
Jennifer Nelson PhD; Group Health institute, Seattle, Washington
David Madigan PhD; Columbia University, New York, NY
Patrick Archdeacon MD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Elizabeth Chrischilles MS, PhD; Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA
Sebastian Schneeweiss MD, ScD; Department of Medicine, Brigham and Women’s Hospital, Boston, MA
